Literature DB >> 1865548

Monoclonal antibodies to endotoxin. New allies against sepsis?

R C Bone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1865548

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Infectious disease therapy in the 1990s. Where are we heading?

Authors:  M Rozenberg-Arska; M R Visser
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

2.  Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?

Authors:  W K Fant
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

3.  Delaying approval of a critical drug: safety, efficacy, economics, compassion.

Authors:  Leo T Rosenberg
Journal:  J Med Humanit       Date:  1994

4.  Monoclonal antibodies in sepsis and septic shock.

Authors:  C J Hinds
Journal:  BMJ       Date:  1992-01-18

Review 5.  The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin.

Authors:  Lara Marks
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

6.  The HA-1A saga: the scientific and ethical dilemma of innovative and costly therapies.

Authors:  C Brun-Buisson
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

7.  In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa.

Authors:  Azmi Adawi; Carlo Bisignano; Tiziana Genovese; Angela Filocamo; Camellia Khouri-Assi; Anat Neville; Giora Z Feuerstein; Salvatore Cuzzocrea; Lewis F Neville
Journal:  Int J Mol Med       Date:  2012-06-20       Impact factor: 4.101

8.  Endotoxemia in critically ill patients: why a reliable test could be beneficial.

Authors:  Robert A Balk
Journal:  Crit Care       Date:  2002-06-20       Impact factor: 9.097
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.